Trial Simulation, Drug Selection To Be Focus Of US FDA's Drug Development Modeling Pilot
Executive Summary
Meeting requests from sponsors that focus on safety prediction will also be prioritized.
You may also be interested in...
Generic Drug Pilot On Model-Informed Evidence Aims To Boost Review Efficiency
US FDA officials, hoping to kick start participation in the pilot, argue modeling decisions made early in development can help streamline the ANDA review later.
Generic Drug Pilot On Model-Informed Evidence Aims To Boost Review Efficiency
US FDA officials, hoping to kick start participation in the pilot, argue modeling decisions made early in development can help streamline the ANDA review later.
Work Presses On To Harmonize Global Expectations On Using Modeling & Simulation
The level at which model-based analyses is integrated into regulatory decision-making can vary between regulatory agencies, from application to application and within agencies for similar submissions, leading to missed opportunities, says the International Council for Harmonisation.